Global Turbocharger Market to Reach $18.67 Billion by 2023, Growing at a CAGR of 6.90%
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Global Turbocharger Market (by Engine Type, Technology, Distribution Channel, Vertical, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)” report has been added to ResearchAndMarkets.com’s offering.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Outlook Therapeutics, Inc. – OTLK
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veradigm Inc. – MDRX
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-652
Asia Pacific Leads the Travel Retail Market Due to Thriving Tourism and Growing Number of Airports
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Global Travel Retail Market (by Product Type, Sale Channel, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The global travel retail mar
REGENXBIO Presents Positive One Year Data from Phase II ALTITUDE® Trial of ABBV-RGX-314 for Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
ABBV-RGX-314 continues to be well tolerated in 50 patients from dose levels 1 and 2 (Cohorts 1-3) with no drug-related serious adverse eventsDose level 2 prevented disease progression and reduced vision-threatening events in non-proliferative diabetic retinopathy patients at 1 Year 70.8% of patient
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DICK’S Sporting Goods, Inc. – DKS
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DICK’S Sporting Goods, Inc. (“Dick’s” or the “Company”) (NYSE: DKS). Such investors are advised to contact Robert S. Willoughby at newaction@pom
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. – SCYX
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. (“SCYNEXIS” or the “Company”) (NASDAQ: SCYX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-652
Quantum Computing Hardware Leads Market Share, While Services Segment Exhibits Highest Growth
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Global Quantum Computing Market (by Component, Application, Technology, End-user, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The glob
Nutraceutical Ingredients Market size to increase by USD 11.16 billion from 2022 to 2027- Technavio
NEW YORK, Nov. 3, 2023 /PRNewswire/ — The nutraceutical ingredients market size is expected to grow by USD 11.16 billion from 2022 to 2027. In addition, the growth momentum of the market will progress at a CAGR of 4.48% during the forecast period, according to Technavio. The health benefits
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Samsara Inc. – IOT
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Samsara Inc. (“Samsara” or the “Company”) (NYSE: IOT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.